Corbus shares will soar or dive soon. Here’s why

Senior Writer, Biotech

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard.

ProMED, an early warning system on disease outbreaks, appears near collapse

The early warning disease network that alerted the world to the original SARS outbreak and the start of the Covid-19 pandemic appears to be in

August 3, 2023

Cresco Q2 Revenue Increases 2% From Q1 to $197.9 Million

Cresco Labs Reports Second Quarter 2023 Results Year-of-the-Core initiatives delivered strong improvements in gross margin, adjusted EBITDA and operating cash flow CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc.

August 16, 2023

F2G inks $100M Series H for another shot at treating fungal infections

Manchester, UK-based F2G has patched together another $100 million in funding a little over a year after receiving a CRL for its experimental fungal infection

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.